Experimental African trypanosomiasis: Effects on plasma melatonin concentration and pineal gland histology in rodents
DOI:
https://doi.org/10.56511/JIPBS.2014.v1.i01.pp01-09Abstract
Trypanosomiasis remains a major public health problem to man over much of tropical Africa. The disease is caused by protozoan parasites of the genus Trypanosoma and is fatal if untreated. The effects of T.b.brucei infection on plasma melatonin concentration and pineal gland histopathology was investigated in male albino rats. Twelve rats were each infected intraperitoneally with 0.2ml of infected blood containing approximately 1.0 x 104 live T.b.brucei parasites. Twelve other rats served as uninfected controls. Trypanosomes were detected in the blood of infected rats 5-8 days post-infection. There was a significant difference (P=0.0382) in plasma melatonin concentration between control and experimental rats. Histopathological changes in the pineal gland of experimental rats included tissue degeneration and pinealocytes with pyknotic nuclei. These histopathological changes were responsible for the decrease in plasma melatonin concentration in the experimental rats.
Keywords:
Trypanosomiasis, Melatonin, Pineal gland, HistopathologyDownloads
References
Kennedy PGE. Difficulties in Diagnostic Staging of Human African Trypanosomiasis. Journal of Neuroparasitology 2011; 2:1-3.
SOS (Stamp out Trypanosomiasis). Human African trypanosomiasis – a neglected disease. 2012. http://www.stampoutsleepingsickness.com /about-sos-/sleeping-sicknessandnagana.aspx . Accessed 15/07/2012.
World Health Organization (WHO): Human African Trypanosomiasis (Sleeping Sickness). Fact sheet No. 259. 2012; http://www.who.int/mediacentre/factsheet s/fs259/en/index.html Accessed 15/07/2012.
Lundkvist GB: Circadian rhythm dysfunction in the suprachiasmatic nucleus: Effects of Trypanosoma brucei brucei infection and inflammatory cytokines. Karolinska University Press, 2001, Stockholm, Sweden. pp 7-23.
Mandela M, Dec R, Marcol W and Kotulska K. Melatonin secretion profile after experimental pineal gland compression in rats. Neuroendocrinol Lett 2003; 24(6):392 – 396.
Macchi M and Bruce J: Human pineal physiology and functional significance of melatonin. Front Neuroendocrinol 2004; 25 (3-4): 177 – 195.
Richardson G: The human circadian system in normal and disordered sleep. J Clin Psychiatry 2005; 66(9): 3 – 9.
Sanchez S, Paredes SD, Martín MI, Barriga C and Rodríguez AB: Effect of tryptophan administration on circulating levels of melatonin and phagocytic activity. J App Biomed 2004; 2: 169-177.
Arendt J: The pineal gland and pineal tumors. 2011: http://www.endotext.org/neuroendo/neuro endo15/neuroendo15.htm Accessed 30/12/12
Gwinner E, Hau M and Heigl S. Melatonin: Generation and modulation of avian circadian rhythms. Brain Research Bulletin 1997; 44: 439-444.
Nelson R and Demas G. Role of melatonin in mediating seasonal energetic and immunologic adaptations. Brain Research Bulletin 1997; 44:423-430.
Reiter R: Pineal melatonin: Cell biology of its synthesis and of its physiological interactions. Endocrine Reviews, 1991; 12(2):151-175.
Schuster C, Gauer F, Malan A, Recio J, Pevet P and Masson-Pevet M. The circadian clock, light/dark cycle and melatonin are differentially involved in the expression of daily and photoperiodic variations in mtl melatonin receptors in Siberian and Syrian hamsters. Neuroendocrinology 2001; 74(1):55-68.
Hilton G. Melatonin and the pineal gland. J Neurosci Nurs 2002; 10:31-39.
Guerrero H, Gauer E, Schuster C, Pevet P and Masson-Pevet M: Melatonin regulates the mRNA expression of the mt1 melatonin receptor in the rat pars tuberalis. Neuroendocrinology 2000; 71:163-169.
Darsaud A, Bourdon L, Chevrier C, Keita M, Bouteille B, Queyroy A, Canini F, Cespuglio R, Dumas M and Buguet A: Clinical Follow-Up in the Rat Experimental Model of AfricanTrypanosomiasis. Soc Exp Bio Med 2003: 1355-1362.
NRC (National Research Council). Guide for th the care and use of laboratory animals. 8 edition. National Academies Press, 2011, Washington, DC. pp 1-55.
Keita M, Bouteille B, Enanga B, Vallat JM and Dumas, M: Trypanosoma brucei brucei: a long-term model of human African trypanosomiasis in mice, meningoencephalitis, astrocytosis, and neurological disorders. Exp Parasitol 1997; 85(2):183192.
Herbert WJ and Lumsden WHR. Trypanasoma brucei: A rapid “ matching ” method for estimating the host's parasitaemia. Exptl. Parasitol. 1976; 40:427431.
OIE Terrestrial Manual. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Trypanosomosis (tse tse-transmitted). 2008; th 6 ed. Vol. 1&2. p813-822. OIE, Paris.
Bowen R: Pineal gland and melatonin. 2003; http://www.vivo.colostate.edu/hbooks/path phys/endocrine/otherendo/index.html. Accessed 16/07/2011 .
Ellis R. Haematoxylin and eosin staining protocol. 2003: http://www.ihcworld.com/_protocols/speci al_stains/h&e_ellis.htm. Accessed 06/08/2011 .
Abenga JN, Sanda SA, and Ezebuiro OGC: Effect of Trypanosoma congolense and Trypanosoma brucei mixed infection on the pattern of haematological changes in murine trypanosomosis. Afr J Clin Expt Microbio 2005;(2):193-197.
Pays E: Antigenic variation in African trypanosomes. In, Progress in human African trypanosomiasis, sleeping sickness. Eds Dumas, Bouteille, and Buguet. 1999; Springer Press. p31-52.
Axelrod J: The pineal gland. Endeavour 1990; 29(108): 144 – 148.
Cardinali DP and Alvarez CB: Melatonin in chagas´ disease. Possible therapeutic value. Medicina (Buenos Aires) 2011; 71: 477-483
Kristensson K, Claustrat B, Mhlanga JDM and Moller M. African trypanosomiasis in the rat alters melatonin secretion and melatonin receptor binding in the suprachiasmatic nucleus. Brain Res Bull 1998; 47 : 265 – 269.
Luke J: Fluoride deposition in the aged human pineal gland. Caries Res 2009; 2991 (35): 125 – 128.
Lundkvist GB, Hill RH and Kristensson K: Disruption of circadian rhythms in synaptic activity of the suprachiasmatic nuclei by African trypanosomes and cytokines. Neurobiol Dis. 2002; 11(1):20-27.
Schultzberg M, Ambatsis M, Samuelsson EB, Kristensson K and van Meirvenne N. Spread of Trypanosoma brucei to the nervous system: early attack on the circumventricular organs and sensory ganglia. J Neurosci Res 1988; 21:51 – 61.
Schultzberg M, Lindberg C, Aronsson AF, Hjorth E, Spulber S and Oprica M. Inflammation in the nervous system – physiological and pathophysiological aspects. Physiol & Behav. 2007; 92(1-2):121-128.
Mulenga C, Mhlanga JDM, Kristensson K and Robertson B. Trypanosoma brucei brucei crosses the blood-brain barrier while tight junction proteins are preserved in a rat chronic disease model. Neuropathol Appl Neurobiol 2001; 27 : 77 – 85.
Masocha W, Robertson B, Rottenberg ME, Mhlanga J, Sorokin L and Kristensson K. Cerebral vessel laminins and IFN- γ define Trypanosoma brucei brucei penetration of the blood-brain barrier. J Clin Invest. 2004; 114(5):689 – 694.
Published
How to Cite
Issue
Section
Copyright (c) 2014 Charles I. Maina, Apolonary O. Oucho, Chebii Kiptanui, Samuel M. Kimani
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at